The promotion of physical activity for the prevention of Alzheimer's disease in adults with Down Syndrome: Rationale and design for a 12 Month randomized trial

Lauren T Ptomey, Amanda N Szabo-Reed, Laura E Martin, Matthew S Mayo, Richard A Washburn, Anna M Gorczyca, Rebecca J Lepping, Phill Lee, Daniel E Forsha, Joseph R Sherman, Jessica C Danon, Joseph E Donnelly, Lauren T Ptomey, Amanda N Szabo-Reed, Laura E Martin, Matthew S Mayo, Richard A Washburn, Anna M Gorczyca, Rebecca J Lepping, Phill Lee, Daniel E Forsha, Joseph R Sherman, Jessica C Danon, Joseph E Donnelly

Abstract

Nearly all individuals with Down Syndrome (DS) display pathology associated with Alzheimer's disease (AD) beginning as early as age 30. Previous research in typically developed adults suggests that increased moderate-to-vigorous physical activity (MVPA) may improve cognitive function and protect against age-related structural and functional changes in the brain; however, the potential impact of increased MVPA on the development of AD in adults with DS has not been evaluated. Despite the potential positive impact of MVPA on cognition and AD risk, participation in MVPA among young adults with DS is low. The limited research evaluating strategies for increasing MVPA in adults with DS has been unsuccessful in increasing MVPA. Results from our preliminary investigation where we remotely delivered real-time MVPA, led by a trained health educator, to groups of adults with DS in their homes via video conferencing on a tablet computer demonstrated high attendance, increased MVPA during group sessions, and improvements in cognitive function. However, the sustainability, impact on total daily MVPA, optimal session frequency, and potential impacts on cognitive function and brain health of remotely delivered group MVPA sessions in adults with DS are unknown. Therefore, we will conduct a trial in 80 non-demented adults with DS to determine the feasibility and potential efficacy of remotely delivered group MVPA sessions to increase daily MVPA, relative to a usual care control. Secondarily we will assess the impact of MVPA on cardiovascular fitness, quality of life, cognitive function and brain parameters related to AD.

Nct registration: NCT04048759.

Keywords: AD, Alzheimer's Disease; Alzheimer's disease; Cognition; DS, Down Syndrome; Down syndrome; MVPA, moderate to vigorous physical activity; Physical activity; RH, remote high; RL, remote low; Technology; UC, Usual Care.

© 2020 The Authors.

References

    1. The World Health Organization Definition: intellectual disability. 2014. Retrieved from World Health Organization Regional Office for Europe website.
    1. De Graaf G., Buckley F., Skotko B.G. Estimation of the number of people with Down syndrome in the United States. Genet. Med. 2017;19(4):439.
    1. Zigman W.B. Atypical aging in Down syndrome. Dev. Disabil. Res. Rev. 2013;18(1):51–67.
    1. Hartley D., Blumenthal T., Carrillo M., DiPaolo G., Esralew L., Gardiner K., Granholm A.-C., Iqbal K., Krams M., Lemere C. Down syndrome and Alzheimer's disease: common pathways, common goals. Alzheimer's & Dementia. 2015;11(6):700–709.
    1. Erickson K.I., Weinstein A.M., Lopez O.L. Physical activity, brain plasticity, and Alzheimer's disease. Arch. Med. Res. 2012;43(8):615–621.
    1. Barnard N.D., Bush A.I., Ceccarelli A., Cooper J., de Jager C.A., Erickson K.I., Fraser G., Kesler S., Levin S.M., Lucey B. Dietary and lifestyle guidelines for the prevention of Alzheimer's disease. Neurobiol. Aging. 2014
    1. Burns J.M., Cronk B.B., Anderson H.S., Donnelly J.E., Thomas G.P., Harsha A., Brooks W.M., Swerdlow R.H. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology. 2008;71(3):210–216.
    1. Honea R., Thomas G.P., Harsha A., Anderson H.S., Donnelly J.E., Brooks W.M., Burns J.M. Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 2009;23(3):188.
    1. Dairo Y.M., Collett J., Dawes H., Oskrochi G.R. Physical activity levels in adults with intellectual disabilities: a systematic review. Prevent. Med. Rep. 2016;4:209–219.
    1. Clarke T., Norris T., Schiller J. Early release of selected estimates based on data from the 2016 national health interview survey. Nat. Center Health Stat. 2017
    1. Melville C.A., Mitchell F., Stalker K., Matthews L., McConnachie A., Murray H.M., Melling C., Mutrie N. Effectiveness of a walking programme to support adults with intellectual disabilities to increase physical activity: walk well cluster-randomised controlled trial. Int. J. Behav. Nutr. Phys. Activ. 2015;12(1):1.
    1. Saunders R.R., Saunders M.D., Donnelly J.E., Smith B.K., Sullivan D.K., Guilford B., Rondon M.F. Evaluation of an approach to weight loss in adults with intellectual or developmental disabilities. Am. J. Intellect. Dev. Disabil. 2011;49(2):103–112.
    1. Ptomey L.T., Saunders R.R., Saunders M., Washburn R.A., Mayo M.S., Sullivan D.K., Gibson C.A., Goetz J.R., Honas J.J., Willis E.A., Danon J.C., Krebill R., Donnelly J.E. Weight management in adults with intellectual and developmental disabilities: a randomized controlled trial of two dietary approaches. J. Appl. Res. Intellect. Disabil. : JARID. 2017 doi: 10.1111/jar.12348. Epub 2017/03/24. PubMed PMID: 28332246.
    1. Temple V.A. Factors associated with high levels of physical activity among adults with intellectual disability. Int. J. Rehabil. Res. 2009;32(1):89–92. doi: 10.1097/MRR.0b013e328307f5a0. Epub 2008/12/17. PubMed PMID: 19077725.
    1. Mahy J., Shields N., Taylor N.F., Dodd K.J. Identifying facilitators and barriers to physical activity for adults with Down syndrome. J. Intellect. Disabil. Res. : JIDR (J. Intellect. Disabil. Res.) 2010;54(9):795–805. doi: 10.1111/j.1365-2788.2010.01308.x. Epub 2010/08/18. PubMed PMID: 20712696.
    1. Ptomey L.T., Szabo A.N., Willis E.A., Gorczyca A.M., Greene J.L., Danon J.C., Donnelly J.E. Changes in cognitive function after a 12-week exercise intervention in adults with Down syndrome. Disabil. Health J. 2018;11(3):486–490. doi: 10.1016/j.dhjo.2018.02.003. Epub 2018/03/05. PubMed PMID: 29501470; PMCID: PMC6005720.
    1. Ptomey L.T., Szabo A.N., Willis E.A., Greene J.L., Danon J.C., Washburn R.A., Forsha D.E., Donnelly J.E. Remote exercise for adults with down syndrome. Transl. J. Am. Coll. Sports Med. 2018;3(8):60–65. Epub 2018/06/23. PubMed PMID: 29930988; PMCID: PMC6005664.
    1. Bandura A. Prentice-Hall; Englewood Cliffs, New Jersey: 1986. Social Foundations of Thought and Action: A Social Cognitive Theory.
    1. Shields N., Taylor N.F. A student-led progressive resistance training program increases lower limb muscle strength in adolescents with Down syndrome: a randomised controlled trial. J. Physiother. 2010;56(3):187–193. Epub 2010/08/28. PubMed PMID: 20795925.
    1. Izquierdo-Gomez R., Veiga O.L., Sanz A., Fernhall B., Diaz-Cueto M., Villagra A. Correlates of objectively measured physical activity in adolescents with Down syndrome: the UP & DOWN study. Nutr. Hosp. 2015;31(6):2606–2617. doi: 10.3305/nh.2015.31.6.8694. Epub 2015/06/05. PubMed PMID: 26040372.
    1. Pitchford E.A., Siebert E., Hamm J., Yun J. Parental perceptions of physical activity benefits for youth with developmental disabilities. Am. J. Intellect. Dev. Disabil. 2016;121(1):25–32. doi: 10.1352/1944-7558-121.1.25. Epub 2015/12/25. PubMed PMID: 26701072.
    1. Izquierdo-Gomez R., Martinez-Gomez D., Fernhall B., Sanz A., Veiga O.L. The role of fatness on physical fitness in adolescents with and without Down syndrome: the UP&DOWN study. Int. J. Obes. 2005:2015. doi: 10.1038/ijo.2015.164. Epub 2015/08/22. PubMed PMID: 26293232.
    1. Deb S., Hare M., Prior L., Bhaumik S. Dementia screening questionnaire for individuals with intellectual disabilities. Br. J. Psychiatr. : J. Ment. Sci. 2007;190:440–444. doi: 10.1192/bjp.bp.106.024984. Epub 2007/05/02. PubMed PMID: 17470960.
    1. Spanos D., Hankey C.R., Boyle S., Koshy P., Macmillan S., Matthews L., Miller S., Penpraze V., Pert C., Robinson N., Melville C.A. Carers' perspectives of a weight loss intervention for adults with intellectual disabilities and obesity: a qualitative study. J. Intellect. Disabil. Res. : JIDR (J. Intellect. Disabil. Res.) 2013;57(1):90–102. doi: 10.1111/j.1365-2788.2011.01530.x. Epub 2012/03/01. PubMed PMID: 22369631.
    1. Ptomey L.T., Sullivan D.K., Lee J., Goetz J.R., Gibson C., Donnelly J.E. The use of technology for delivering a weight loss program for adolescents with intellectual and developmental disabilities. J. Acad. Nutr. Diet. 2015;115(1):112–118. doi: 10.1016/j.jand.2014.08.031. Epub 2014/12/03. PubMed PMID: 25441960.
    1. Melville C.A., Boyle S., Miller S., Macmillan S., Penpraze V., Pert C., Spanos D., Matthews L., Robinson N., Murray H., Hankey C.R. An open study of the effectiveness of a multi-component weight-loss intervention for adults with intellectual disabilities and obesity. Br. J. Nutr. 2011;105(10):1553–1562. doi: 10.1017/s0007114510005362. Epub 2011/01/25. PubMed PMID: 21255473.
    1. Spanos D., Hankey C.R., Melville C.A. The effectiveness of a weight maintenance intervention for adults with intellectual disabilities and obesity: a single stranded study. J. Appl. Res. Intellect. Disabil. : JARID. 2015 doi: 10.1111/jar.12181. Epub 2015/04/29. PubMed PMID: 25916495.
    1. Martinez-Zaragoza F., Campillo-Martinez J.M., Ato-Garcia M. Effects on physical health of a multicomponent programme for overweight and obesity for adults with intellectual disabilities. J. Appl. Res. Intellect. Disabil. : JARID. 2015 doi: 10.1111/jar.12177. Epub 2015/04/08. PubMed PMID: 25847077.
    1. Pett M., Clark L., Eldredge A., Cardell B., Jordan K., Chambless C., Burley J. Effecting healthy lifestyle changes in overweight and obese young adults with intellectual disability. Am. J. Intellect. Dev. Disabil. 2013;118(3):224–243. doi: 10.1352/1944-7558-118.3.224. Epub 2013/06/06. PubMed PMID: 23734617.
    1. McCarran M.S., Andrasik F. Behavioral weight-loss for multiply-handicapped adults: assessing caretaker involvement and measures of behavior change. Addict. Behav. 1990;15(1):13–20. Epub 1990/01/01. PubMed PMID: 2138405.
    1. Hithersay R., Strydom A., Moulster G., Buszewicz M. Carer-led health interventions to monitor, promote and improve the health of adults with intellectual disabilities in the community: a systematic review. Res. Dev. Disabil. 2014;35(4):887–907. doi: 10.1016/j.ridd.2014.01.010. Epub 2014/02/06. PubMed PMID: 24495402.
    1. Humphries K., Traci M.A., Seekins T. Food on file: pilot test of an innovative method for recording food intake of adults with intellectual disabilities living in the community. J. Appl. Res. Intellect. Disabil. 2008;21(2):126–173.
    1. Haskell W.L., Lee I.M., Pate R.R., Powell K.E., Blair S.N., Franklin B.A., Macera C.A., Heath G.W., Thompson P.D., Bauman A. Physical activity and public health: updated recommendation for adults from the American College of sports medicine and the American heart association. Med. Sci. Sports Exerc. 2007;39(8):1423–1434.
    1. Physical Activity Guidelines Adivsory Committee Report, 2008. Department of Health and Human Services; Washington, DC: 2008.
    1. Croce R.V., Pitetti K.H., Horvat M., Miller J. Peak torque, average power, and hamstrings/quadriceps ratios in nondisabled adults and adults with mental retardation. Arch. Phys. Med. Rehabil. 1996;77(4):369–372. Epub 1996/04/01. PubMed PMID: 8607761.
    1. Saunders R.R., Saunders M.D. An analsis of contingency learning in the treatment of aberrant behavior. J. Dev. Phys. Disabil. 2000;7(54-83)
    1. Butte N.F., Ekelund U., Westerterp K.R. Assessing physical activity using wearable monitors: measures of physical activity. Med. Sci. Sports Exerc. 2012;44(1 Suppl 1):S5–S12. doi: 10.1249/MSS.0b013e3182399c0e. Epub 2011/12/23. PubMed PMID: 22157774.
    1. Trost S.G., McIver K.L., Pate R.R. Conducting accelerometer-based activity assessments in field-based research. Med. Sci. Sports Exerc. 2005;37(11 Suppl):S531–S543. Epub 2005/11/19. PubMed PMID: 16294116.
    1. Hendelman D., Miller K., Baggett C., Debold E., Freedson P. Validity of accelerometry for the asssesment of moderate intensity physical activity in the field. Med. Sci. Sports Exerc. 2000;32:S442–S449. Suppl.
    1. Nordstrøm M., Hansen B.H., Paus B., Kolset S.O. Accelerometer-determined physical activity and walking capacity in persons with Down syndrome, Williams syndrome and Prader–Willi syndrome. Res. Dev. Disabil. 2013;34(12):4395–4403.
    1. Izquierdo-Gomez R., Martínez-Gómez D., Acha A., Veiga O.L., Villagra A., Diaz-Cueto M., UP, group Ds Objective assessment of sedentary time and physical activity throughout the week in adolescents with Down syndrome. The UP&DOWN study. Res. Dev. Disabil. 2014;35(2):482–489.
    1. Kang M., Bjornson K., Barreira T.V., Ragan B.G., Song K. The minimum number of days required to establish reliable physical activity estimates in children aged 2-15 years. Physiol. Meas. 2014;35(11):2229–2237. doi: 10.1088/0967-3334/35/11/2229. Epub 2014/10/24. PubMed PMID: 25340374.
    1. Cain K.L., Sallis J.F., Conway T.L., Van Dyck D., Calhoon L. Using accelerometers in youth physical activity studies: a review of methods. J. Phys. Activ. Health. 2013;10(3):437–450. Epub 2013/04/27. PubMed PMID: 23620392.
    1. Hildebrand M., Vanh V.T., Hansen B.H., Ekelund U. Age group comparability of raw accelerometer output from wrist- and hip-worn monitors. Med. Sci. Sports Exerc. 2014;46(9):1816–1824. doi: 10.1249/mss.0000000000000289. Epub 2014/06/03. PubMed PMID: 24887173.
    1. Troiano R.P., Berrigan D., Dodd K.W., Masse L.C., Tilert T., McDowell M. Physical activity in the United States measured by accelerometer. Med. Sci. Sports Exerc. 2008;40(1):181–188. Epub 2007/12/20. PubMed PMID: 18091006.
    1. Matthews C.E., Chen K.Y., Freedson P.S., Buchowski M.S., Beech B.M., Pate R.R., Troiano R.P. Amount of time spent in sedentary behaviors in the United States, 2003-2004. Am. J. Epidemiol. 2008;167(7):875–881.
    1. Masse L.C., Fuemmeler B.F., Anderson C.B., Matthews C.E., Trost S.G., Catellier D.J., Treuth M.S. Accelerometer data reduction: a comparison of four reduction algorithms on select outcome variables. Med. Sci. Sports Exerc. 2005;37(11):S544–S554. Suppl.
    1. Falconer D.W., Cleland J., Fielding S., Reid I.C. Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory. Psychol. Med. 2010;40(6):1017–1025. doi: 10.1017/s0033291709991243. Epub 2009/09/25. PubMed PMID: 19775495.
    1. Fernie G., Bennett D.M., Currie J., Perrin J.S., Reid I.C. Detecting objective and subjective cognitive effects of electroconvulsive therapy: intensity, duration and test utility in a large clinical sample. Psychol. Med. 2014;44(14):2985–2994. doi: 10.1017/s0033291714000658. Epub 2014/07/30. PubMed PMID: 25065412.
    1. Soares F.C., de Oliveira T.C., de Macedo L.D., Tomas A.M., Picanco-Diniz D.L., Bento-Torres J., Bento-Torres N.V., Picanco-Diniz C.W. CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative study. Clin. Interv. Aging. 2015;10:37–48. doi: 10.2147/cia.s68186. Epub 2015/01/08. PubMed PMID: 25565785; PMCID: Pmc4279672.
    1. Robbins T.W., James M., Owen A.M., Sahakian B.J., Lawrence A.D., McInnes L., Rabbitt P.M. A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery. J. Int. Neuropsychol. Soc. : JINS. 1998;4(5):474–490. Epub 1998/09/24. PubMed PMID: 9745237.
    1. Kim H.S., An Y.M., Kwon J.S., Shin M.S. A preliminary validity study of the cambridge neuropsychological test automated battery for the assessment of executive function in schizophrenia and bipolar disorder. Psychiatr. Invest. 2014;11(4):394–401. doi: 10.4306/pi.2014.11.4.394. Epub 2014/11/15. PubMed PMID: 25395970; PMCID: Pmc4225203.
    1. Cooper S.-A., Caslake M., Evans J., Hassiotis A., Jahoda A., McConnachie A., Morrison J., Ring H., Starr J., Stiles C. Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial. Trials. 2014;15(1):202.
    1. Vicari S., Pontillo M., Armando M. Neurodevelopmental and psychiatric issues in Down's syndrome: assessment and intervention. Psychiatr. Genet. 2013;23(3):95–107.
    1. Pennington B.F., Moon J., Edgin J., Stedron J., Nadel L. The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev. 2003;74(1):75–93. Epub 2003/03/11. PubMed PMID: 12625437.
    1. Égerházi A., Berecz R., Bartók E., Degrell I. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease. Prog. Neuro Psychopharmacol. Biol. Psychiatr. 2007;31(3):746–751.
    1. Fernhall B., Millar L., Tymeson G., Burkett L. Cardiovascular fitness testing and fitness levels of adolescents and adults with mental retardation including Down syndrome. Educ. Train. Ment. Retard. 1989:133–138.
    1. Fernhall B., McCubbin J.A., Pitetti K.H., Rintala P., Rimmer J.H., Millar A.L., De Silva A. Prediction of maximal heart rate in individuals with mental retardation. Med. Sci. Sports Exerc. 2001;33(10):1655–1660. PubMed PMID: 11581548.
    1. ACMS's . ninth ed. Lippincott, Williams and Wilkens; Baltimore MD: 2014. Guidelines for Exercise Testing and Prescription.
    1. McGillivray J., Lau A.Y., Cummins R., Davey G. The utility of the well-being intellectual disability scale in an Australian sample. J. Appl. Res. Intellect. Disabil. 2009;22(3):276–286.
    1. Cummins R., Lau A.L., Davey G., McGillivray J. Measuring subjective well-being: the personal well-being Index - intellectual disability. In: Kober R., editor. Enhancing the Quality of Life of People with Disability. Springer, Inc.; New York, NY: 2010. pp. 33–46.
    1. Erickson K.I., Grove G.A., Burns J.M., Hillman C.H., Kramer A.F., McAuley E., Vidoni E.D., Becker J.T., Butters M.A., Gray K., Huang H., Jakicic J.M., Kamboh M.I., Kang C., Klunk W.E., Lee P., Marsland A.L., Mettenburg J., Rogers R.J., Stillman C.M., Sutton B.P., Szabo-Reed A., Verstynen T.D., Watt J.C., Weinstein A.M., Wollam M.E. Investigating gains in neurocognition in an intervention trial of exercise (IGNITE): protocol. Contemp. Clin. Trials. 2019;85:105832. doi: 10.1016/j.cct.2019.105832. Epub 2019/08/30. PubMed PMID: 31465859; PMCID: PMC6815730.
    1. Matthews D.C., Lukic A.S., Andrews R.D., Marendic B., Brewer J., Rissman R.A., Mosconi L., Strother S.C., Wernick M.N., Mobley W.C. Dissociation of Down syndrome and Alzheimer's disease effects with imaging. Alzheimer's Dementia: Transl. Res. Clin. Intervent. 2016;2(2):69–81.
    1. Rafii M., Wishnek H., Brewer J., Donohue M., Ness S., Mobley W., Aisen P., Rissman R. The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome. Front. Behav. Neurosci. 2015;9:239.
    1. Lao P.J., Handen B.L., Betthauser T.J., Cody K.A., Cohen A.D., Tudorascu D.L., Stone C.K., Price J.C., Johnson S.C., Klunk W.E. Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation. Brain Imag. Behav. 2018:1–9.
    1. Moeller S., Yacoub E., Olman C.A., Auerbach E., Strupp J., Harel N., Ugurbil K. Multiband multislice GE-EPI at 7 tesla, with 16-fold acceleration using partial parallel imaging with application to high spatial and temporal whole-brain fMRI. Magn. Reson. Med. 2010;63(5):1144–1153. doi: 10.1002/mrm.22361. Epub 2010/05/01. PubMed PMID: 20432285; PMCID: PMC2906244.
    1. Feinberg D.A., Moeller S., Smith S.M., Auerbach E., Ramanna S., Gunther M., Glasser M.F., Miller K.L., Ugurbil K., Yacoub E. Multiplexed echo planar imaging for sub-second whole brain FMRI and fast diffusion imaging. PloS One. 2010;5(12) doi: 10.1371/journal.pone.0015710. Epub 2010/12/29. PubMed PMID: 21187930; PMCID: PMC3004955.
    1. Xu J., Moeller S., Auerbach E.J., Strupp J., Smith S.M., Feinberg D.A., Yacoub E., Ugurbil K. Evaluation of slice accelerations using multiband echo planar imaging at 3 T. Neuroimage. 2013;83:991–1001. doi: 10.1016/j.neuroimage.2013.07.055. Epub 2013/08/01. PubMed PMID: 23899722; PMCID: PMC3815955.
    1. Cox R.W. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput. Biomed. Res. 1996;29(3):162–173. Epub 1996/06/01. PubMed PMID: 8812068.
    1. Pierpaoli C., Walker L., Irfanoglu M.O., Barnett A., Basser P., Chang L.-C., Koav C., Pajevic S., Rohde G., Sarlls J., Wu M. ISMRM 18th Annual Meeting; Stockholm, Sweden. 2010. TORTOISE: an integrated software package for processing of diffusion MRI data.
    1. Irfanoglu M.O., Nayak A., Jenkins J., Pierpaoli C. ISMRM 25th Annual Meeting; Honolulu, HI. 2017. TORTOISEv3: improvements and new features of the NIH diffusion MRI processing pipeline.
    1. Irfanoglu M.O., Modi P., Nayak A., Hutchinson E.B., Sarlls J., Pierpaoli C. DR-BUDDI (Diffeomorphic Registration for Blip-Up blip-Down Diffusion Imaging) method for correcting echo planar imaging distortions. Neuroimage. 2015;106:284–299. doi: 10.1016/j.neuroimage.2014.11.042. Epub 2014/11/30. PubMed PMID: 25433212; PMCID: PMC4286283.
    1. Wang Y., Moeller S., Li X., Vu A.T., Krasileva K., Ugurbil K., Yacoub E., Wang D.J. Simultaneous multi-slice Turbo-FLASH imaging with CAIPIRINHA for whole brain distortion-free pseudo-continuous arterial spin labeling at 3 and 7 T. Neuroimage. 2015;113:279–288.
    1. Kilroy E., Apostolova L., Liu C., Yan L., Ringman J., Wang D.J. Reliability of 2D and 3D pseudo-continuous arterial spin labeling perfusion MRI in elderly populations–comparison with 15O-water PET. J. Magn. Reson. Imag.: JMRI. 2014;39(4):931.
    1. Jann K., Smith R., Piedra E.R., Xiao X., Wang D.J. 2017. LOFT_CBFquantify.m. 3.0 Ed.
    1. Wang Z., Aguirre G.K., Rao H., Wang J., Fernández-Seara M.A., Childress A.R., Detre J.A. Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn. Reson. Imag. 2008;26(2):261–269.
    1. Friston K.J., Ashburner J., Frith C.D., Poline J.B., Heather J.D., Frackowiak R.S. Spatial registration and normalization of images. Hum. Brain Mapp. 1995;3(3):165–189.
    1. Lohman T.G., Roche A.F., Martorell R. Human Kinetics Books; Champaign,Ill: 1988. Anthropometric Standardization Reference Manual. 1988.
    1. Braun V., Clarke V. Using thematic analysis in psychology. Qual. Res. Psychol. 2006;3(2):77–101.
    1. Enders C.K. Guilford Press; New York, NY: 2010. Applied Missing Data Analysis.
    1. Schafer J.L., Graham J.W. Missing data: our view of the state-of-the-art. Psychol. Methods. 2002;7:147–177.
    1. Graham J.W., Cumsille P.E., Elk-Fisk E. John Wiley & Sons; New York, NY: 2003. Research Methods in Psychology. pp.87–114.
    1. McCarron M., McCallion P., Reilly E., Mulryan N. A prospective 14‐year longitudinal follow‐up of dementia in persons with D own syndrome. J. Intellect. Disabil. Res. 2014;58(1):61–70.
    1. Englund A., Jonsson B., Zander C.S., Gustafsson J., Annerén G. Changes in mortality and causes of death in the Swedish Down syndrome population. Am. J. Med. Genet. 2013;161(4):642–649.
    1. Wiseman F.K., Al-Janabi T., Hardy J., Karmiloff-Smith A., Nizetic D., Tybulewicz V.L., Fisher E.M., Strydom A. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat. Rev. Neurosci. 2015;16(9):564.
    1. Mann D.M. The pathological association between Down syndrome and Alzheimer disease. Mechan. Age. Dev. 1988;43(2):99–136. Epub 1988/05/01. PubMed PMID: 2969441.
    1. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., Masters C.L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 1989;320(22):1446–1452. doi: 10.1056/nejm198906013202203. Epub 1989/06/01. PubMed PMID: 2566117.
    1. Barnes D.E., Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10(9):819–828.
    1. Andel R., Crowe M., Pedersen N.L., Fratiglioni L., Johansson B., Gatz M. Physical exercise at midlife and risk of dementia three decades later: a population-based study of Swedish twins. J. Gerontol. Ser. A: Biol. Sci. Med. Sci. 2008;63(1):62–66.
    1. DeFina L.F., Willis B.L., Radford N.B., Gao A., Leonard D., Haskell W.L., Weiner M.F., Berry J.D. The association between midlife cardiorespiratory fitness levels and later-life DementiaA cohort study. Ann. Intern. Med. 2013;158(3):162–168.
    1. Rimmer J.H., Heller T., Wang E., Valerio I. Improvements in physical fitness in adults with Down syndrome. Am. J. Ment. Retard. 2004;109(2):165–174.
    1. Mendonca G.V., Pereira F.D., Fernhall B. Effects of combined aerobic and resistance exercise training in adults with and without Down syndrome. Arch. Phys. Med. Rehabil. 2011;92(1):37–45.
    1. Boer P.H., Moss S.J. Effect of continuous aerobic vs. interval training on selected anthropometrical, physiological and functional parameters of adults with Down syndrome. J. Intellect. Disabil. Res. : JIDR (J. Intellect. Disabil. Res.) 2016 doi: 10.1111/jir.12251. Epub 2016/01/26. PubMed PMID: 26805768.
    1. Shields N., Taylor N.F., Wee E., Wollersheim D., O'Shea S.D., Fernhall B. A community-based strength training programme increases muscle strength and physical activity in young people with Down syndrome: a randomised controlled trial. Res. Dev. Disabil. 2013;34(12):4385–4394.
    1. Bartlo P., Klein P.J. Physical activity benefits and needs in adults with intellectual disabilities: systematic review of the literature. Am. J. Intellect. Dev. Disabil. 2011;116(3):220–232.
    1. Bodde A.E., Seo D.-C., Frey G.C., Lohrmann D.K., Van Puymbroeck M. Developing a physical activity education curriculum for adults with intellectual disabilities. Health Promot. Pract. 2012;13(1):116–123.
    1. Ptomey L.T., Washburn R.A., Mayo M.S., Greene J.L., Lee R.H., Szabo-Reed A.N., Honas J.J., Sherman J.R., Donnelly J.E. Remote delivery of weight management for adults with intellectual and developmental disabilities: rationale and design for a 24 month randomized trial. Contemp. Clin. Trials. 2018;73:16–26.
    1. Penedo F.J., Dahn J.R. Exercise and well-being: a review of mental and physical health benefits associated with physical activity. Curr. Opin. Psychiatr. 2005;18(2):189–193.
    1. Martin C.K., Church T.S., Thompson A.M., Earnest C.P., Blair S.N. Exercise dose and quality of life: a randomized controlled trial. Arch. Intern. Med. 2009;169(3):269–278.
    1. Lavie C.J., Arena R., Swift D.L., Johannsen N.M., Sui X., Lee D-c, Earnest C.P., Church T.S., O’keefe J.H., Milani R.V. Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. Circ. Res. 2015;117(2):207–219.
    1. dos Santos E.S., Asano R.Y., Irênio Filho G., Lopes N.L., Panelli P., Nascimento DdC., Collier S.R., Prestes J. Acute and chronic cardiovascular response to 16 weeks of combined eccentric or traditional resistance and aerobic training in elderly hypertensive women: a randomized controlled trial. J. Strength Condit Res. 2014;28(11):3073–3084.
    1. Olson E.A., McAuley E. Impact of a brief intervention on self-regulation, self-efficacy and physical activity in older adults with type 2 diabetes. J. Behav. Med. 2015;38(6):886–898.
    1. McAuley E., Blissmer B., Katula J., Duncan T.E., Mihalko S.L. Physical activity, self-esteem, and self-efficacy relationships in older adults: a randomized controlled trial. Ann. Behav. Med. 2000;22(2):131.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe